Featured, News, Trade Ideas

Pioneering B-TRAN Technology to Expand Applications in EVs, Renewable Energy, and Data Centers

December 4, 2024 No comments yet

Ideal Power (IPWR) has announced a significant milestone in its commercialization journey with a multi-unit order for its SymCool IQ intelligent power module. The order comes from a customer specializing in circuit protection and power conversion solutions, marking a promising expansion of Ideal Power’s market reach.

The customer, already familiar with Ideal Power’s SymCool power modules and drivers, is exploring SymCool and SymCool IQ modules for applications in solid-state circuit protection and power conversion across sectors such as electric vehicles (EVs), EV charging, renewable energy, and data centers.

“This multi-unit order for our SymCool IQ is a significant milestone in the commercialization of our B-TRAN technology,” stated Dan Brdar, CEO of Ideal Power. “SymCool IQ opens up additional markets for us, including renewable energy, energy storage, and EV charging. This customer is evaluating SymCool IQ for use in pairing renewable energy with energy storage to leverage the improved efficiency and bidirectionality of our technology.”

The SymCool IQ module builds on Ideal Power’s innovative B-TRAN multi-die packaging with an integrated intelligent driver optimized for bidirectional operation. Rated at 1200V and 200A, SymCool IQ outperforms traditional IGBT modules by offering lower losses, inherent bidirectionality, and reduced thermal management requirements. These advantages lead to increased energy savings, lower operating costs, and compact, cost-effective solutions for OEMs.

Additionally, SymCool IQ includes protection features such as overcurrent and undervoltage protection, along with temperature sensing. Its standard 62-millimeter package makes it a versatile choice for industrial power semiconductor applications.

With this order, Ideal Power is poised to deepen its presence in transformative sectors like renewable energy and EV infrastructure, signaling strong momentum for its patented B-TRAN technology.

Read original press release here

You might like this article: Telomir Pharmaceuticals Announces Breakthrough in Type 2 Diabetes Treatment with Telomir-1

Leave a Reply

Your email address will not be published. Required fields are marked *

Continue reading

Featured, News, Trade Ideas

European Markets Open Higher Amid Holiday Week, Novo Nordisk Rebounds

December 23, 2024 No comments yet

Markets Begin Festive Week on a Positive Note as Novo Nordisk Recovers From Friday’s Plunge European markets started the week on a positive trajectory, with the pan-European Stoxx 600 index gaining 0.4% in early Monday trading. Most sectors posted gains as investors settled into a shortened trading week ahead of the Christmas holiday. Positive Momentum […]

Featured, News, Trade Ideas

Why My Size and Taoping Shares Are Soaring

December 20, 2024 No comments yet

Shares of My Size (NASDAQ: MYSZ) and Taoping Inc. (NASDAQ: TAOP) are experiencing explosive upward momentum today, catching the attention of investors and market watchers. Here’s a closer look at the factors driving these dramatic moves. My Size Soars 400% on Unusual Trading Activity My Size, a company specializing in AI-driven measurement solutions, saw its […]

News

PainReform Soars 500% in a Single Day: What’s Driving the Surge?

December 19, 2024 No comments yet

PainReform Ltd. (NASDAQ: PRFX), a clinical-stage pharmaceutical company specializing in innovative pain management solutions, experienced an extraordinary 500% surge in its stock price today. This dramatic rise has caught the attention of investors and analysts alike, raising questions about the factors fueling such rapid growth. A Breakthrough in Pain Management PainReform is focused on addressing […]